Sellas Life Sciences Group Inc (NASDAQ:SLS)
| 1.34 Delayed Data As of Mar 17 |  -0.03 / -2.17%Today’s Change | 1.27 Today|||52-Week Range 7.40 | -43.22% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Stergiou Angelos M President & Chief Executive Officer |  Sale | 12/05/2022 | 6,494 | $2.61 | $16.9K | -46.43% |
Wood Barbara A | Sale | 12/05/2022 | 2,153 | $2.59 | $5.6K | -46.43% |
Burns John T | Sale | 12/05/2022 | 1,159 | $2.59 | $3.0K | -46.43% |
Kalin Katherine Bach Director |  Gift | 2/02/2023 | 2,500 | $0.00 | $0.00 | -59.58% |
Scheinberg David A Director | Gift | 2/02/2023 | 2,500 | $0.00 | $0.00 | -59.58% |
Van Nostrand Robert L Director | Gift | 2/02/2023 | 2,500 | $0.00 | $0.00 | -59.58% |
Wasman Jane Director | Gift | 2/02/2023 | 2,500 | $0.00 | $0.00 | -59.58% |
Varian John W Director | Gift | 2/02/2023 | 2,500 | $0.00 | $0.00 | -59.58% |
Francomano Robert M Chief Commercial Officer | Gift | 2/02/2023 | 12,000 | $0.00 | $0.00 | -59.58% |
Stergiou Angelos M President & Chief Executive Officer | Gift | 2/02/2023 | 58,000 | $0.00 | $0.00 | -59.58% |
Page of 2